Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis

Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis

This data is the supplementary data for a manuscript entitled "Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis". In our study, we showed that dupilumab was an effective and safe treatment cho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Yuanyuan Xu
Format: Dataset
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Yuanyuan Xu
description This data is the supplementary data for a manuscript entitled "Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis". In our study, we showed that dupilumab was an effective and safe treatment choice for children and adolescents with AD. More long-term, high-quality, controlled studies in different regions are in demand for further verification.
doi_str_mv 10.17632/76czfxgmvb.2
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_17632_76czfxgmvb_2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_17632_76czfxgmvb_2</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_17632_76czfxgmvb_23</originalsourceid><addsrcrecordid>eNqVzz1qAzEQBWA1KUyS0v1cYB3vGmxIGxx8gPRiLI2yA_pZNGMn8jFy4tiLIXWqV7yPB8-YZb9e9bvtZnjZbd0lfH-m83E1LMzPPgR26Bpg9iAYSBtMtQSOBCWAP00cTwmPEEoFHQm0EmqirLcatUzswFNNqKwswBncyNFXyvMk-hJJ3NXLKyBIE6WbdVDpzPQ1o0SKHWaMTViezEPAKPR8z0fTve8_3g6dR0XHSnaqnLA226_t_Mn-fbLD5r_-F-2tYII</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis</title><source>DataCite</source><creator>Yuanyuan Xu</creator><creatorcontrib>Yuanyuan Xu</creatorcontrib><description>This data is the supplementary data for a manuscript entitled "Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis". In our study, we showed that dupilumab was an effective and safe treatment choice for children and adolescents with AD. More long-term, high-quality, controlled studies in different regions are in demand for further verification.</description><identifier>DOI: 10.17632/76czfxgmvb.2</identifier><language>eng</language><publisher>Mendeley</publisher><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1887</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.17632/76czfxgmvb.2$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Yuanyuan Xu</creatorcontrib><title>Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis</title><description>This data is the supplementary data for a manuscript entitled "Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis". In our study, we showed that dupilumab was an effective and safe treatment choice for children and adolescents with AD. More long-term, high-quality, controlled studies in different regions are in demand for further verification.</description><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2022</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNqVzz1qAzEQBWA1KUyS0v1cYB3vGmxIGxx8gPRiLI2yA_pZNGMn8jFy4tiLIXWqV7yPB8-YZb9e9bvtZnjZbd0lfH-m83E1LMzPPgR26Bpg9iAYSBtMtQSOBCWAP00cTwmPEEoFHQm0EmqirLcatUzswFNNqKwswBncyNFXyvMk-hJJ3NXLKyBIE6WbdVDpzPQ1o0SKHWaMTViezEPAKPR8z0fTve8_3g6dR0XHSnaqnLA226_t_Mn-fbLD5r_-F-2tYII</recordid><startdate>20221206</startdate><enddate>20221206</enddate><creator>Yuanyuan Xu</creator><general>Mendeley</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20221206</creationdate><title>Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis</title><author>Yuanyuan Xu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_17632_76czfxgmvb_23</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Yuanyuan Xu</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Yuanyuan Xu</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis</title><date>2022-12-06</date><risdate>2022</risdate><abstract>This data is the supplementary data for a manuscript entitled "Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis". In our study, we showed that dupilumab was an effective and safe treatment choice for children and adolescents with AD. More long-term, high-quality, controlled studies in different regions are in demand for further verification.</abstract><pub>Mendeley</pub><doi>10.17632/76czfxgmvb.2</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.17632/76czfxgmvb.2
ispartof
issn
language eng
recordid cdi_datacite_primary_10_17632_76czfxgmvb_2
source DataCite
title Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T01%3A01%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Yuanyuan%20Xu&rft.date=2022-12-06&rft_id=info:doi/10.17632/76czfxgmvb.2&rft_dat=%3Cdatacite_PQ8%3E10_17632_76czfxgmvb_2%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true